Innovative OTC Stock Today

IMTH -  USA Stock  

USD 0.50  0.00  0.00%

Innovative Medtech is trading at 0.5 as of the 19th of October 2021. This is a No Change since the beginning of the trading day. The stock's open price was 0.5. Innovative Medtech has more than 68 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Innovative Medtech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of October 2019 and ending today, the 19th of October 2021. Click here to learn more.
 Market Performance
6 of 100
  Odds Of Distress
Over 68
Innovative MedTech Inc. provides natural and organic food products. Innovative MedTech Inc. is headquartered in New York, New York. Innovative Medtech operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. The company has 163.56 K outstanding shares. More on Innovative Medtech
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Innovative Medtech OTC Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Innovative Medtech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Innovative Medtech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Innovative Medtech is way too risky over 90 days horizon
Innovative Medtech has some characteristics of a very speculative penny stock
Innovative Medtech appears to be risky and price may revert if volatility continues
Innovative Medtech has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (365.34 K).
Innovative Medtech currently holds about 608 in cash with (4.39 K) of positive cash flow from operations.
Latest headline from This Unstoppable Cancer-Treatment Companys Stock Is on Sale Now - Nasdaq
Legal NameInnovative Medtech
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Innovative Medtech's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellOvervalued
Innovative Medtech [IMTH] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Nano-Cap' category with current market capitalization of 81.78 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Innovative Medtech's market, we take the total number of its shares issued and multiply it by Innovative Medtech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Innovative Medtech conducts business under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 163.56 K outstanding shares. Innovative Medtech currently holds about 608 in cash with (4.39 K) of positive cash flow from operations.
Check Innovative Medtech Probability Of Bankruptcy

Innovative Stock Price Odds Analysis

What are Innovative Medtech's target price odds to finish over the current price? In reference to a normal probability distribution, the odds of Innovative Medtech jumping above the current price in 90 days from now is about 86.78%. The Innovative Medtech probability density function shows the probability of Innovative Medtech otc stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Innovative Medtech has a beta of -10.9409. This usually indicates as returns on its benchmark rise, returns on holding Innovative Medtech are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Innovative Medtech is expected to outperform its benchmark. In addition to that, the company has an alpha of 4.151, implying that it can generate a 4.15 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Odds Down 0.5HorizonTargetOdds Up 0.5 
13.18%90 days
Based on a normal probability distribution, the odds of Innovative Medtech to move above the current price in 90 days from now is about 86.78 (This Innovative Medtech probability density function shows the probability of Innovative OTC Stock to fall within a particular range of prices over 90 days) .

Innovative Medtech Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Innovative Medtech market risk premium is the additional return an investor will receive from holding Innovative Medtech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Innovative Medtech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Innovative Medtech's alpha and beta are two of the key measurements used to evaluate Innovative Medtech's performance over the market, the standard measures of volatility play an important role as well.

Innovative Stock Against Markets

Picking the right benchmark for Innovative Medtech otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Innovative Medtech otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Innovative Medtech is critical whether you are bullish or bearish towards Innovative Medtech at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Innovative Medtech without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Balance Of Power Now


Balance Of Power

Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
All  Next Launch Module
Please see Risk vs Return Analysis. Note that the Innovative Medtech information on this page should be used as a complementary analysis to other Innovative Medtech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Commodity Channel Index module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Innovative OTC Stock analysis

When running Innovative Medtech price analysis, check to measure Innovative Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovative Medtech is operating at the current time. Most of Innovative Medtech's value examination focuses on studying past and present price action to predict the probability of Innovative Medtech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Innovative Medtech's price. Additionally, you may evaluate how the addition of Innovative Medtech to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
The market value of Innovative Medtech is measured differently than its book value, which is the value of Innovative that is recorded on the company's balance sheet. Investors also form their own opinion of Innovative Medtech's value that differs from its market value or its book value, called intrinsic value, which is Innovative Medtech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innovative Medtech's market value can be influenced by many factors that don't directly affect Innovative Medtech underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innovative Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine Innovative Medtech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innovative Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.